{"id":93279,"date":"2023-08-04T12:47:00","date_gmt":"2023-08-04T10:47:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=93279"},"modified":"2023-08-04T09:54:22","modified_gmt":"2023-08-04T07:54:22","slug":"bind-x-series-b","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/93279\/bind-x-series-b\/","title":{"rendered":"Bind-X receives 10 million euros in Series B"},"content":{"rendered":"<div class=\"entry-content\">\n<p>Bind-X (formerly <a href=\"\/en\/startups\/dust-biosolutions-gmbh\/\">Dust Biosolutions<\/a>), based at the IZB in Martinsried, aims to make agriculture, mining, and the infrastructure sector more sustainable through the use of bio-based products. To achieve this, the startup relies on the biogeochemical process of microbiologically induced calcite precipitation. Microorganisms ensure that calcium carbonate accumulates in the soil, thus solidifying it. This is intended to bind dust, control weeds, and reduce the use of bitumen in road construction, among other things.<\/p>\n\n\n\n<p>The startup has now successfully completed its Series B financing round. The \u20ac10 million raised will be invested primarily in international expansion and further market entry. The capital comes from HG Ventures, the corporate venture arm of the US-based Heritage Group. Also participating are Berlin-based VC Saxovent, Swiss investor Greeneering Invest, and K&amp;K 1, a first-time investor.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Bind-X is a \u201cgreat example of a novel technology\u201d<\/h2>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>\u201cWe are thrilled by the strong interest in our Series B financing round and grateful for the trust that both our existing shareholders (HTGF and Vantage Value) and new investors have placed in Bind-X,\u201d<\/p><\/blockquote>\n\n\n\n<p>says <strong>Martin Spitznagel<\/strong>, Founder and CEO of Bind-X.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>\u201cThis financing will enable us to further drive our global expansion, increase our production capacity accordingly, and further expand our team at what are now three international locations.\u201d<\/p><\/blockquote>\n\n\n\n<p><strong>Kay Balster<\/strong>, Principal at High-Tech Gr\u00fcnderfonds (HTGF), says about the new investors:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;Our new shareholders ideally complement the existing consortium. Their relevant industry experience will further enhance the current momentum and lead to strong growth in our core markets.&quot;<\/p><\/blockquote>\n\n\n\n<p>The IZB, where Bind-X is based, is also pleased about the financing round. <strong>Peter Hanns Zobel<\/strong>, Managing Director of <a href=\"\/en\/day\/izb\/\">IZB<\/a>, explained:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;We are delighted that Bind-X was able to raise a significant round of funding in increasingly challenging times for financing. The biotech company is a great example of a novel technology, of which there are many at the IZB. Our thanks also go to the investors who remain steadfast and believe in Bind-X and the location. I am confident that Bind-X will continue to market its revolutionary technology and advance its vision of improving the sustainability and profitability of industries through the optimization, adaptation, and industrialization of biotechnological processes.&quot;<\/p><\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The Munich-based biotech startup Bind-X has successfully completed its Series B financing round, raising \u20ac10 million. Investors include HG Ventures, K&amp;K 1, Greeneering Invest, and Saxovent.<\/p>","protected":false},"author":33,"featured_media":93281,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1,5635],"tags":[4925,52,1499],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bind-X erh\u00e4lt 10 Millionen Euro in Series-B - Munich Startup<\/title>\n<meta name=\"description\" content=\"Das M\u00fcnchner Biotech-Startup Bind-X hat erfolgreich seine Series-B-Finanzierungsrunde abgeschlossen und 10 Millionen Euro eingesammelt.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/93279\/bind-x-series-b\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bind-X erh\u00e4lt 10 Millionen Euro in Series-B - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Das M\u00fcnchner Biotech-Startup Bind-X hat erfolgreich seine Series-B-Finanzierungsrunde abgeschlossen und 10 Millionen Euro eingesammelt.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/93279\/bind-x-series-b\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-04T10:47:00+00:00\" \/>\n<meta name=\"author\" content=\"Maximilian Feigl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maximilian Feigl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/\",\"url\":\"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/\",\"name\":\"Bind-X erh\u00e4lt 10 Millionen Euro in Series-B - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/08\/Bind-X-Team-Photo-scaled-1.jpg\",\"datePublished\":\"2023-08-04T10:47:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\"},\"description\":\"Das M\u00fcnchner Biotech-Startup Bind-X hat erfolgreich seine Series-B-Finanzierungsrunde abgeschlossen und 10 Millionen Euro eingesammelt.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/08\/Bind-X-Team-Photo-scaled-1.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/08\/Bind-X-Team-Photo-scaled-1.jpg\",\"width\":2048,\"height\":1362,\"caption\":\"Bind-X-CTO Luitpold Fried, CPO Martin Krehenbrink und CEO Martin Spitznagel\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bind-X erh\u00e4lt 10 Millionen Euro in Series-B\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\",\"name\":\"Maximilian Feigl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"caption\":\"Maximilian Feigl\"},\"description\":\"Maximilian Feigl berichtet seit 2020 \u00fcber das M\u00fcnchner Startup \u00d6kosystem. Dabei haben es dem studierten Politikwissenschaftler vor allem Deeptech-Themen angetan.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2023\/08\/Bind-X-Team-Photo-scaled-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1362\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bind-X receives 10 million euros in Series B - Munich Startup","description":"The Munich-based biotech startup Bind-X has successfully completed its Series B financing round and raised 10 million euros.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/93279\/bind-x-series-b\/","og_locale":"en_US","og_type":"article","og_title":"Bind-X erh\u00e4lt 10 Millionen Euro in Series-B - Munich Startup","og_description":"Das M\u00fcnchner Biotech-Startup Bind-X hat erfolgreich seine Series-B-Finanzierungsrunde abgeschlossen und 10 Millionen Euro eingesammelt.","og_url":"https:\/\/cms.munich-startup.net\/en\/93279\/bind-x-series-b\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2023-08-04T10:47:00+00:00","author":"Maximilian Feigl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Maximilian Feigl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/","url":"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/","name":"Bind-X receives 10 million euros in Series B - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/08\/Bind-X-Team-Photo-scaled-1.jpg","datePublished":"2023-08-04T10:47:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509"},"description":"The Munich-based biotech startup Bind-X has successfully completed its Series B financing round and raised 10 million euros.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/08\/Bind-X-Team-Photo-scaled-1.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/08\/Bind-X-Team-Photo-scaled-1.jpg","width":2048,"height":1362,"caption":"Bind-X-CTO Luitpold Fried, CPO Martin Krehenbrink und CEO Martin Spitznagel"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/93279\/bind-x-series-b\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Bind-X erh\u00e4lt 10 Millionen Euro in Series-B"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509","name":"Maximilian Feigl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","caption":"Maximilian Feigl"},"description":"Maximilian Feigl has been reporting on the Munich startup ecosystem since 2020. The political scientist is particularly interested in deeptech topics.","url":"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/"}]},"og_image":[{"width":2048,"height":1362,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/08\/Bind-X-Team-Photo-scaled-1.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1691139842:42","_edit_last":"33","_yoast_wpseo_focuskw":"Bind-X","_yoast_wpseo_metadesc":"Das M\u00fcnchner Biotech-Startup Bind-X hat erfolgreich seine Series-B-Finanzierungsrunde abgeschlossen und 10 Millionen Euro eingesammelt.","_yoast_wpseo_linkdex":"78","_thumbnail_id":"93281","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"90","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/93279"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=93279"}],"version-history":[{"count":2,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/93279\/revisions"}],"predecessor-version":[{"id":93284,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/93279\/revisions\/93284"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/93281"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=93279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=93279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=93279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}